What's in Gelb, Arthur F., M.D.'s pipeline?

Gelb, Arthur F., M.D. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Gelb, Arthur F., M.D.'s portfolio?

Top competitors by shared drug class: Allergy & Asthma Medical Group & Research Center, Allergy and Asthma Center of El Paso, AstraZeneca, Chiesi Farmaceutici S.p.A., Far Eastern Memorial Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/gelb-arthur-f-m-d.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Gelb, Arthur F., M.D. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gelb, Arthur F., M.D. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
fluticasone/salmeterol in all asthmatics	fluticasone/salmeterol in all asthmatics	marketed	Inhaled corticosteroid/long-acting beta-2 agonist combination	Glucocorticoid receptor (fluticasone); beta-2 adrenergic receptor (salmeterol)	Respiratory/Pulmonology

Therapeutic area mix

Respiratory/Pulmonology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Allergy & Asthma Medical Group & Research Center · 1 shared drug class
Allergy and Asthma Center of El Paso · 1 shared drug class
AstraZeneca · 1 shared drug class
Chiesi Farmaceutici S.p.A. · 1 shared drug class
Far Eastern Memorial Hospital · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Istituto per la Ricerca e l'Innovazione Biomedica · 1 shared drug class
AO GENERIUM · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Gelb, Arthur F., M.D.:

Cite this brief

Drug Landscape (2026). Gelb, Arthur F., M.D. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/gelb-arthur-f-m-d. Accessed 2026-05-16.